MindMaze Therapeutics plans MindMotion Lite tablet home neurorehab
MindMaze Therapeutics said it will release MindMotion Lite, a tablet-based version of its MindMotion neurotherapeutic activities for home deployment, expected by year-end 2026.
MindMaze Therapeutics said it expects by year-end 2026 to launch MindMotion Lite, a tablet-based version of its MindMotion neurotherapeutic activities designed for simpler home deployment. GENEVA, Sept. 17, 2026 // -- MindMaze Therapeutics (SIX:MMTX), a global leader in scalable precision neurotherapeutics…